MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1210/jc.2009-1879

Медицинская библиотека · The Journal of clinical endocrinology and metabolism · 2009

Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene.

Aguiar-Oliveira Manuel H, Oliveira Francielle T, Pereira Rossana M C, Oliveira Carla R P, Blackford Amanda, Valenca Eugenia H O, Santos Elenilde G, Gois-Junior Miburge B, Meneguz-Moreno Rafael A, Araujo Vanessa P, Oliveira-Neto Luis A, Almeida Roque P, Santos Mário A, Farias Natalia T, Silveira Debora C R, Cabral Gabriel W, Calazans Flavia R, Seabra Juliane D, Lopes Tiago F, Rodrigues Endrigo O, Porto Livia A, Oliveira Igor P, Melo Enaldo V, Martari Marco, Salvatori Roberto

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

CONTEXT: Reduced longevity observed in hypopituitarism has been attributed to GH deficiency (GHD). It is, however, unclear whether GHD or other confounding factors cause this early mortality.

OBJECTIVE

The aim was to study longevity in subjects from a large kindred with untreated, lifetime isolated GHD (IGHD) due to a homozygous mutation in the GHRH receptor gene and in heterozygous carriers of the mutation.

DESIGN, SETTING, AND

PARTICIPANTS

We carried out a retrospective cohort study on three groups. We first compared mortality risk of 65 IGHD individuals and their 128 unaffected siblings from 34 families. We then compared mean age of death of the IGHD to the general population. A transversal study was carried out to compare the rate of heterozygosity for the mutation in two groups of young (20-40 yr old) and old (60-80 yr old) normal-appearing subjects from the same county.

MAIN OUTCOME MEASURE: We measured longevity.

RESULTS

The risk of death of IGHD subjects was not different from their siblings. Life span in IGHD individuals was shorter than the general population. When stratified by sex, this difference persisted only in females, due to a high frequency of IGHD deaths in females aged 4-20. There was no significant difference in life span between IGHD subjects and siblings or the general population when analyzing subjects who reached age 20. The prevalence of heterozygosity did not differ in young and old groups, suggesting no survival advantage or disadvantage.

CONCLUSIONS

In a selected genetic background, lifelong untreated IGHD does not affect longevity.

Для цитирования: Aguiar-Oliveira Manuel H, Oliveira Francielle T, Pereira Rossana M C, Oliveira Carla R P, Blackford Amanda, Valenca Eugenia H O, Santos Elenilde G, Gois-Junior Miburge B, Meneguz-Moreno Rafael A, Araujo Vanessa P, Oliveira-Neto Luis A, Almeida Roque P, Santos Mário A, Farias Natalia T, Silveira Debora C R, Cabral Gabriel W, Calazans Flavia R, Seabra Juliane D, Lopes Tiago F, Rodrigues Endrigo O, Porto Livia A, Oliveira Igor P, Melo Enaldo V, Martari Marco, Salvatori Roberto. Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene.. The Journal of clinical endocrinology and metabolism. 2009. DOI: 10.1210/jc.2009-1879.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.